| Current Medical Articles |
|---|
 |
Chemistry World
May 8, 2013
Phillip Broadwith |
Clinical trial data release blocked by companies Two pharmaceutical companies have been granted injunctions to prevent the European Medicines Agency from releasing clinical trial data about their drugs.   |
Chemistry World
May 8, 2013
Josh Howgego |
Sound approach to drug testing Using pipettes for serial dilutions in drug discovery work could generate misleading data, a new study suggests. |
Chemistry World
May 7, 2013
Phillip Broadwith |
AstraZeneca site to become biotech hub The first three companies have already moved in, and more will hopefully follow to fill the space left by AZ as it relocates to Cambridge, UK. |
Chemistry World
May 7, 2013
Phillip Broadwith |
Buy Viagra online - direct from the manufacturer Pharmaceutical giant Pfizer is cutting out the pharmacist middle-man by setting up a website for Viagra (sildenafil citrate) sales. |
Chemistry World
May 3, 2013
Phillip Broadwith |
Judge reverses jury decision over $6.5m Takeda payout A judge has thrown out the jury's verdict in a case between Japanese drugmaker Takeda and a US man who claims that the company's drug caused his bladder cancer. |
Chemistry World
April 29, 2013 |
Bayer buys Conceptus for $1.1bn The deal gives Bayer access to Essure, a non-surgical procedure for permanent birth control. |
Chemistry World
April 25, 2013
Phillip Broadwith |
Portable detector shines light on fake drugs The CD-3 counterfeit detection device uses a variety of different wavelengths of light to visually compare tablets, capsules and their packaging with genuine reference samples. |
Chemistry World
April 24, 2013
Phillip Broadwith |
US sues Novartis over alleged kickbacks Novartis has used illegal payments to induce pharmacies to switch kidney transplant patients onto its immunosuppressant drug Myfortic (mycophenolate sodium), a US government lawsuit alleges. |
Chemistry World
April 23, 2013
Phillip Broadwith |
Ireland picks preferred drugs Ireland has become the first country to identify lists of 'preferred drugs'. Ensuring patients use the best value-for-money drugs could save patients and taxpayers millions of euros, says the Irish Health Service Executive. |
Chemistry World
April 19, 2013
Phillip Broadwith |
Objections raised to GSK pay-for-delay deals The UK Office of Fair Trading has said that GlaxoSmithKline's deals to delay generic drugs infringed competition laws. |
Chemistry World
April 19, 2013
Sarah Houlton |
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. |
Chemistry World
April 17, 2013
Mark Peplow |
Sanofi launches malaria drug production On 11 April, the Paris-based pharmaceutical company Sanofi officially launched a new production facility in Garessio, Italy, to make artemisinin -- the precursor to artemisinin-based combination therapies, the most effective drugs against the deadliest malaria parasite. |
Chemistry World
April 9, 2013
Phillip Broadwith |
Morning sickness drug reintroduced to US Diclegis (doxylamine succinate and pyridoxine hydrochloride), contains the same active ingredients as Benedictin, which was produced by Merrel Dow and withdrawn from the market in 1983 after a string of lawsuits claiming it caused birth defects. |
Chemistry World
April 9, 2013
Emma Stoye |
Drug restrictions delay magic mushroom trial The first clinical trial to explore the antidepressant effects of psilocybin, the hallucinogenic component of magic mushrooms, has been delayed by EU and UK drug regulations. |
Chemistry World
April 8, 2013
Sarah Houlton |
India rejects Novartis patent appeal India's Supreme Court has denied Novartis' appeal against the decision to refuse patent protection for its anticancer drug Glivec (imatinib mesylate). |
Chemistry World
April 8, 2013
Philip Robinson |
The truth about snake oil? US scientists have carried out the first analyses of old 'patent medicines' - medicinal preparations from the turn of the last century - to identify the chemical constituents of the medications and perhaps determine if there was any truth in the wild health claims they made. |
Chemistry World
April 5, 2013
Phillip Broadwith |
Roche to release Tamiflu trial data Swiss pharma company Roche has finally agreed to give independent researchers access to data on all 74 clinical trials it ran on the antiviral influenza drug Tamiflu (oseltamivir). |
Chemistry World
April 4, 2013
Phillip Broadwith |
Regeneron expands, creating 400 new jobs US biotech Regeneron has announced that it will expand its corporate headquarters and laboratories in Tarrytown. |
Chemistry World
April 4, 2013
Phillip Broadwith |
Amylin headquarters to close with further job losses Bristol-Myers Squibb has confirmed that it will be closing the site in San Diego, US, which was formerly the corporate headquarters of biotech firm Amylin. |
Chemistry World
April 2, 2013
Kerek Lowe |
From lab to leader Here's a topic that always gets people arguing: how much of a scientist should the chief executive of a biopharma company be? |
Chemistry World
April 2, 2013
Bibiana Campos Seijo |
More job cuts... The news came in that AstraZeneca is to invest 330 million pounds in a new strategic R&D center and global headquarters in Cambridge, UK. Unfortunately, there is also a negative angle to this story. |
| There are 8617 old articles available for this category. |
